Renflexis
-
Merck Launches Renflexis, a Biosimilar Version of Remicade
Merck has launched a biosimilar version of Remicade, Johnson & Johnson’s blockbuster drug, writes John George for Philadelphia Business Journal.…
Renflexis

Merck has launched a biosimilar version of Remicade, Johnson & Johnson’s blockbuster drug, writes John George for Philadelphia Business Journal.…